Moyle PM - Search Results

1

Formulation and Biological Evaluation of Mesoporous Silica Nanoparticles Loaded with Combinations of Sortase A Inhibitors and Antimicrobial Peptides.

Alharthi S, Ziora ZM, Janjua T, Popat A, Moyle PM. Alharthi S, et al. Among authors: moyle pm. Pharmaceutics. 2022 May 4;14(5):986. doi: 10.3390/pharmaceutics14050986. Pharmaceutics. 2022. PMID: 35631572 Free PMC article.

2

Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccine.

Ahmad Fuaad AA, Jia Z, Zaman M, Hartas J, Ziora ZM, Lin IC, Moyle PM, Batzloff MR, Good MF, Monteiro MJ, Skwarczynski M, Toth I. Ahmad Fuaad AA, et al. Among authors: moyle pm. Nanomedicine (Lond). 2014 Jan;9(1):35-43. doi: 10.2217/nnm.13.7. Epub 2013 Apr 23. Nanomedicine (Lond). 2014. PMID: 23611619

3

Sortase A (SrtA) inhibitors as an alternative treatment for superbug infections.

Alharthi S, Alavi SE, Moyle PM, Ziora ZM. Alharthi S, et al. Among authors: moyle pm. Drug Discov Today. 2021 Sep;26(9):2164-2172. doi: 10.1016/j.drudis.2021.03.019. Epub 2021 Mar 27. Drug Discov Today. 2021. PMID: 33781954 Review.

4

Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.

Alharthi S, Ziora ZM, Moyle PM. Alharthi S, et al. Among authors: moyle pm. Bioorg Med Chem. 2021 Dec 15;52:116527. doi: 10.1016/j.bmc.2021.116527. Epub 2021 Nov 20. Bioorg Med Chem. 2021. PMID: 34839159

5

Sortase A Inhibitor Protein Nanoparticle Formulations Demonstrate Antibacterial Synergy When Combined with Antimicrobial Peptides.

Alharthi S, Popat A, Ziora ZM, Moyle PM. Alharthi S, et al. Among authors: moyle pm. Molecules. 2023 Feb 24;28(5):2114. doi: 10.3390/molecules28052114. Molecules. 2023. PMID: 36903360 Free PMC article.

6

Dispersibility of phospholipids and their optimization for the efficient production of liposomes using supercritical fluid technology.

Maqbool F, Moyle PM, Thurecht KJ, Falconer JR. Maqbool F, et al. Among authors: moyle pm. Int J Pharm. 2019 May 30;563:174-183. doi: 10.1016/j.ijpharm.2019.03.053. Epub 2019 Mar 30. Int J Pharm. 2019. PMID: 30940503

7

Glucagon-Like Peptide-1 Receptor Agonists and Strategies To Improve Their Efficiency.

Alavi SE, Cabot PJ, Moyle PM. Alavi SE, et al. Among authors: moyle pm. Mol Pharm. 2019 Jun 3;16(6):2278-2295. doi: 10.1021/acs.molpharmaceut.9b00308. Epub 2019 May 13. Mol Pharm. 2019. PMID: 31050435 Review.

8

A Self-Adjuvanting Vaccine Platform: Optimization of Site-Specific Sortase A Mediated Conjugation of Toll-Like Receptor 2 Ligands onto the Carboxyl or Amino terminus of Recombinant Protein Antigens.

Xu Z, Moyle PM. Xu Z, et al. Among authors: moyle pm. Chempluschem. 2020 Jan;85(1):227-236. doi: 10.1002/cplu.201900687. Chempluschem. 2020. PMID: 31944609

9

Developing GLP-1 Conjugated Self-Assembling Nanofibers Using Copper-Catalyzed Alkyne-Azide Cycloaddition and Evaluation of Their Biological Activity.

Alavi SE, Cabot PJ, Raza A, Moyle PM. Alavi SE, et al. Among authors: moyle pm. Bioconjug Chem. 2021 Apr 21;32(4):810-820. doi: 10.1021/acs.bioconjchem.1c00091. Epub 2021 Apr 12. Bioconjug Chem. 2021. PMID: 33843208

10

Peptide-based targeted polymeric nanoparticles for siRNA delivery.

Hussein WM, Cheong YS, Liu C, Liu G, Begum AA, Attallah MA, Moyle PM, Torchilin VP, Smith R, Toth I. Hussein WM, et al. Among authors: moyle pm. Nanotechnology. 2019 Oct 11;30(41):415604. doi: 10.1088/1361-6528/ab313d. Epub 2019 Jul 11. Nanotechnology. 2019. PMID: 31295734

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page